Evidence map›Paper›PMID 42046624›Full record

ArticleCureus2026

Chemical Assault Burns Leading to Multi-organ Complications and End-Organ Damage: A Case Series.

Alizah Khan, Tasnim Mustafa, Shiza Ali, Yasmin H Kazim

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alizah KhanClinical Sciences Department, Dubai Medical University, Dubai, ARE.
Tasnim MustafaClinical Sciences Department, Dubai Medical University, Dubai, ARE.
Shiza AliClinical Sciences Department, Dubai Medical University, Dubai, ARE.
Yasmin H KazimEmergency Department, Rashid Hospital - Dubai Health, Dubai, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report presents two cases of extensive chemical burn injuries following acute exposure. The first involved a 24-year-old previously healthy female who sustained deep dermal and full-thickness burns over 44% of total body surface area, including the face, neck, chest, and upper limbs. Her injuries were complicated by circumferential limb burns, ocular involvement with corneal damage, and rhabdomyolysis leading to early acute kidney injury. Management required airway protection, aggressive fluid resuscitation, serial debridements, staged skin grafting, and reconstructive surgery. After seven months of hospitalization, she was discharged with stable grafts, preserved limb function, partial visual impairment, and significant scarring. The second case involved a 33-year-old male with 38% full-thickness burns affecting the face, neck, and upper body, accompanied by airway compromise, metabolic acidosis, coagulopathy, rhabdomyolysis, and progressive renal failure necessitating dialysis. Early intubation, escharotomy, and intensive supportive care were instituted. He required prolonged ventilation and multiple grafting and contracture release procedures. After six months, he achieved full clinical recovery. These cases highlight that chemical burns exceeding 30% total body surface area (TBSA) can precipitate overt disseminated intravascular coagulation (DIC), rhabdomyolysis-driven acute kidney injury (AKI), and multi-organ dysfunction even in the absence of initial haemodynamic instability, underscoring the need for early biochemical surveillance protocols and proactive multidisciplinary escalation from the time of presentation.

Indexed as

assault injurycaustic substancedisseminated intravascular coagulation (dic)full-thickness burnmultiple-organ failure

Identifiers

PMID42046624
PMCPMC13110717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.